The world’s first “practical data”: Israel confirms that the vaccine significantly reduces the spread of the virus
Visit: Alibaba Cloud “Warm Cloud” theme event-30 million subsidies to help small and medium-sized enterprises break through the cold winter
This data is the first time that the effectiveness of the new crown vaccine has been confirmed in the real world. Although it has not yet been peer reviewed, it provides hope for curbing the spread of the virus.
It is reported that the data of this Israeli study was collected within three weeks as of February 6, during which Pfizer vaccine was the only vaccine available in Israel. During this time, more than 27% of Israel’s population over 15 years of age were fully vaccinated.
Specifically, 4.4% of the severe and critically ill patients received two vaccinations, and 5.7% of the patients who died from the new crown were fully vaccinated. Overall, Pfizer vaccines are 93% effective in preventing hospitalization and death.
It is worth noting that during the data collection period, the British variant strain (B.1.1.7) was the main strain spread in Israel, accounting for more than 81% of the tested samples. Therefore, the Israeli research results support the previous laboratory data that the vaccine is very effective against the British variant strain.
In fact, in early February this year, an Israeli study has shown that after a large-scale vaccination of the new crown vaccine, the Israeli epidemic has finally been effectively controlled, becoming the first overseas country to successfully contain the epidemic through a vaccine.
According to the data of the Tel Aviv University research team in Israel, compared with the peak in mid-January, the daily new infection rate of elderly people over 60 in Israel has dropped by 46%, and the infection rate of young people under 60 A decrease of 18%.